Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03828097 · ClinicalTrials.gov registry record · NA
The Effects of a Multi-vitamin Supplement in Adult Females
A NA study of Health, Subjective, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 1
- Study location
NCT03828097: Completed NA study of Health, Subjective, sponsored by Auburn University.
NCT03828097 is a NA study of Health, Subjective that has completed, run by Auburn University. The registered enrollment target is 94 participants, below the 440-participant average among 4 other Health, Subjective trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03828097, a NA study of Health, Subjective, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are examining how the daily consumption of a multi-vitamin/mineral supplement affects the following variables in 21-40 year old women: 1. blood levels of various micronutrients (assessed from blood draws using mass spectrometry-based assays) 2. blood cell gene expression patterns (assessed from blood draws and real-time PCR assays) 3. mood (assessed via questionnaires) Blood and questionnaires will be collected prior to supplementation, and 12 weeks into supplementation.
Primary Outcome
Blood serum will be collected at PRE and POST-intervention and assessed for 25-hydroxycholecalciferol (25OHD), and folate as well as 6 associated metabolites \[folic acid, 5-methyltetrahydrofolate (5-MeTHF), 5-formyltetrahydrofolate (5-FoTHF), homocysteine (Hcy), S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH)\]. Overall changes in these metabolites will be compared to pre-intervention values to determine if the experimental intervention was more effective at increasing one or multip
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Experimental supplement
Study Locations (1)
Alabama
- School of Kinesiology, Auburn University - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
What the finished NCT03828097 record still lists
NCT03828097 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 440-participant average among 4 other Health, Subjective trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Health, Subjective appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03828097 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03828097 about?
NCT03828097 is a clinical study titled "The Effects of a Multi-vitamin Supplement in Adult Females". The investigators are examining how the daily consumption of a multi-vitamin/mineral supplement affects the following variables in 21-40 year old women: 1. blood levels of various micronutrients (assessed from blood draws using mass spectrometry-based assays) 2. blood cell gene expression patterns ...
What is the current status of trial NCT03828097?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2018-05-01. Estimated completion is 2019-06-01.
What conditions does trial NCT03828097 study?
This clinical trial studies the following conditions: Health, Subjective.
What interventions are being tested in trial NCT03828097?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Experimental supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03828097?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03828097 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health, Subjective
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Florida Community-Engaged Research Alliance (FL-CEAL)
RECRUITING · NA
-
The IGNITE Study on Concentrated Investment in Black Neighborhoods
ACTIVE NOT RECRUITING · NA
-
The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI